PO
VIRX

Private Ocean’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Private Ocean’s Portfolio VIRX Stock Details VIRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$2 Buy
+3
New +$2 ﹤0.01% 618
2024
Q1 		– Sell
-3
Closed -$2 – 565
2023
Q4 		$2 Hold
3
– – ﹤0.01% 514
2023
Q3 		$3 Buy
+3
New +$4 ﹤0.01% 478

Other funds holding VIRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Private Ocean's VIRX Position: Q2 2024 in Review

Private Ocean opened a new position in Viracta Therapeutics, Inc. Common Stock (VIRX) in Q2 2024: 3 shares worth $2. The stake represents ﹤0.01% of the portfolio and ranks #618 among its holdings. This is a return to the name: Private Ocean previously reported a position in VIRX as recently as Q4 2023.

Private Ocean first reported a position in VIRX in Q3 2023 and has held it in 3 quarters since. The position peaked at $3 in Q3 2023. 40 funds tracked by Wall St. Rank hold VIRX as of Q2 2024.

  • Private Ocean held 3 shares of Viracta Therapeutics, Inc. Common Stock worth $2 as of Q2 2024.
  • Viracta Therapeutics, Inc. Common Stock was a new Private Ocean position in Q2 2024.
  • Viracta Therapeutics, Inc. Common Stock made up ﹤0.01% of Private Ocean's portfolio in Q2 2024, its #618 holding.
  • Private Ocean first reported a position in Viracta Therapeutics, Inc. Common Stock in Q3 2023 and has held it in 3 quarters since.
  • Private Ocean's Viracta Therapeutics, Inc. Common Stock position peaked at $3 in Q3 2023.
  • 40 funds tracked by Wall St. Rank held Viracta Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Private Ocean's 13F filing for Q2 2024, filed 30 Jul 2024.